Overview
- Kivo Health raised an oversubscribed $10 million Series A led by Allumia Ventures to expand its AI-powered virtual care platform for seniors with chronic diseases.
- The company is starting with chronic obstructive pulmonary disease (COPD), using virtual pulmonary rehabilitation and proactive clinical support to improve patient outcomes and reduce hospitalizations.
- The funding brings Kivo’s total raised capital to more than $16 million and will support nationwide expansion and development of its AI platform.
The News
Kivo Health has secured $10 million in Series A funding, led by Allumia Ventures, with participation from Corewell Health Ventures, Y Combinator, Heuristic Capital, and MassMutual Ventures. The investment will support nationwide expansion, strengthen health plan partnerships, and advance the company’s AI-powered care platform.
Kivo combines virtual clinical teams with AI-enabled support to help seniors manage COPD at home. Its virtual pulmonary rehabilitation program aims to overcome barriers associated with traditional facility-based care, including mobility limitations, transportation challenges, and geographic isolation.
A peer-reviewed study of Kivo’s program reported a 24% improvement in symptoms, a 34% improvement in functional capacity, a 25% improvement in mood, and 83% median program attendance. An independent actuarial analysis also estimated potential healthcare savings of $8,245 per member annually through reductions in hospitalizations, emergency department visits, and nursing home days.
Kivo’s programs are covered by major health plans, including UnitedHealthcare, Humana, Blue Cross, Aetna, Priority Health, Medicare, and Medicaid. The company plans to expand into additional high-cost chronic conditions over time.
Industry Perspective
COPD remains a significant healthcare burden, yet access to pulmonary rehabilitation is limited despite its established clinical benefits. Virtual care can help address this gap by bringing supervised rehabilitation and ongoing clinical support into patients’ homes. AI may further support care coordination and earlier intervention, although long-term outcomes and cost savings will depend on implementation and patient engagement.
Strategic Impact
The funding positions Kivo Health to scale a virtual-first model focused on improving chronic disease management among older adults. By combining clinically supported rehabilitation with AI-enabled care, the company aims to reduce avoidable hospital utilization while improving quality of life. Its planned expansion into other chronic conditions could broaden its addressable market and strengthen its role in value-based healthcare delivery.
Source: Businesswire
